Project Grant R50CA305205
Award Date 9/17/25
Completion Date 8/31/29
Dollars Obligated $547K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Colorado, USA
Similar Awards
- This $575,051 Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will support the University of Arizona Cancer Center (UACC) in enhancing its NCI-funded clinical research enterprise over a 5-year period from September 1, 2025 to August 31, 2030. The key objectives are to grow the breadth of the UACC's clinical trial portfolio to better serve its diverse patient population, increase accruals to interventional treatment trials (especially NCI-sponsored...
- The University of Kansas Medical Center Research Institute, Inc. (KUMCRI) has been awarded a $135,951 Project Grant from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) to enhance access to breast cancer prevention clinical trials. The project aims to modernize engagement and delivery of cancer prevention research, with a focus on improving recruitment and representation of all populations in breast cancer prevention trials. The award supports research initiatives to...
- This Project Grant award of $357,694 from the National Cancer Institute (CFDA Program 93.393 - Cancer Cause and Prevention Research) aims to conduct research on health insurance disparities and their impact on cancer outcomes. The project, titled "Health Insurance and Disparities: More Than Access," will build on an established linkage between the Colorado Central Cancer Registry and the Colorado All-Payer Claims Database to analyze the role of plan type, patient demographics,...
- The federal Project Grant award of $369,564.00 was provided by the National Cancer Institute (NCI) under the Cancer Research Manpower (CFDA 93.398) program. The award supports the "STUDENTS AND TEACHERS ACHIEVING CANCER RESEARCH EXPERIENCES TOGETHER (START) PROGRAM" aimed at expanding representation of underserved secondary school students in science careers through cancer research and education initiatives in the community surrounding the University of Colorado Anschutz Medical Campus...
- The National Cancer Institute (NCI) awarded a $491,315 Project Grant under the Cancer Biology Research program (CFDA 93.396) to the University of Colorado Cancer Center (UCCC). The grant will support the work of Dr. Molishree Joshi, Associate Director of the Functional Genomics Shared Resource (FGSR) at UCCC, to further develop and expand the FGSR's capabilities in providing essential functional genomics technologies and services to academic researchers across Colorado. The FGSR, under Dr....
- This federal Project Grant award of $584,510.00, provided by the National Cancer Institute (NCI) under the Cancer Biology Research program (CFDA 93.396), supports the development of advanced spatial transcriptomics and proteomics technologies for studying tumor microenvironments. The award enables the University of Colorado-Denver to implement new imaging techniques and computational approaches to enhance the capabilities of its Human Immune Monitoring Shared Resource (HIMSR). This will allow...
- The National Cancer Institute (NCI) awarded a $361,695 Project Grant under the Cancer Treatment Research program (CFDA 93.395) to the University of Oklahoma Health Sciences Center (OUHSC) for the period of September 1, 2025 to August 31, 2029. The grant aims to: 1) Leverage novel mHealth applications to boost enrollment in NCI-sponsored clinical trials, 2) Promote representative clinical trial enrollment from the local catchment area population, 3) Expand Veteran access to NCI trials, and 4)...
- The National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, awarded a $1,338,648 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to the University of Pittsburgh. The grant will fund a "Hybrid Type I Cluster Randomized Effectiveness-Implementation Trial of CARES" to address clinically significant levels of depression, pain, and fatigue experienced by over 18 million Americans living with cancer. The project aims to...
- This $375,134 Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) supports research to develop a novel approach for reducing the off-target accumulation of chemotherapeutic nanomedicines. The key objectives are to characterize an innate immune response that can be leveraged to limit nanoparticle deposition in healthy tissues, thereby enhancing delivery to tumors and improving the efficacy of chemotherapy. The 5-year project, starting on March 1, 2025,...
- The University of Colorado-Denver was awarded a $1,344,022 Project Grant by the National Cancer Institute (CFDA 93.396 - Cancer Biology Research) to investigate the role of respiratory viral infections and inflammation in promoting metastatic outgrowth of breast cancer in the lung. The 5-year grant, with an award date of March 1, 2025, aims to determine the mechanisms by which acute respiratory viral infections induce the awakening of dormant disseminated cancer cells, leading to metastatic...